CVE-2026-24164

CRITICAL EPSS 37.3%
Published Mar 31, 20263mo ago · Modified Jun 17, 20262w ago
9.8 CVSS 3.1
Critical
Find Similar
Published Mar 31, 2026 3mo ago
Last Modified Jun 17, 2026 2w ago

Description

NVIDIA BioNeMo contains a vulnerability where a user could cause a deserialization of untrusted data. A successful exploit of this vulnerability might lead to code execution, denial of service, information disclosure, and data tampering.

CVSS Details

Base Score
9.8
Exploitability
3.9
Impact
5.9
Vector string
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
Attack Vector Network
Attack Complexity Low
Privileges Required None
User Interaction None
Scope Unchanged
Confidentiality High
Integrity High
Availability High

Threat Intelligence

EPSS Exploit Probability
37.3% percentile
Exploit & Patch Status
No Known Exploit
No Patch Available

Weaknesses 1

CWE-502 Deserialization of Untrusted Data Validation

Affected Products 1

VendorProductVersionRange
nvidiabionemo_framework* <2026-01-21

References 3

  • nvd.nist.gov https://nvd.nist.gov/vuln/detail/CVE-2026-24164
    Third Party AdvisoryUS Government Resource
  • nvidia.custhelp.com https://nvidia.custhelp.com/app/answers/detail/a_id/5808
    Vendor Advisory
  • cve.org https://www.cve.org/CVERecord?id=CVE-2026-24164
    Third Party Advisory

Remediation

No remediation data recorded yet

Check vendor advisories and the NVD entry for patch availability.